Rongrong Liu

2 clinical trials · Sponsor

Record	Firm	Date
Evaluating the Clinical Efficacy and Safety of Luspatercept Combined With Thalidomide in the Treatment of β-TDT Patients (NCT07338344)	Rongrong Liu	2026-02-01
Evaluation of Recombinant Humanized Anti-CD25 Monoclonal Antibody for Preventing Graft-versus-host Disease After Haploidentical/matched Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Transfusion-dependent Thalassemia (NCT06657391)	Rongrong Liu	2024-10-01

Every clearance here is in the API, with alerts when new ones post.